← Back to patent-cliff list
羟乙基淀粉130/0.4
Tier C — Watch / tradeHydroxyethyl starch 130 / 0.4
-
Originator
2006
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Updating
Indications (approved)：血容量不足
Regional status
US
-
EU
-
China
批准上市
2006-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Hydroxyethyl starch 130 / 0.4?
Approved indications include: 血容量不足.
When does the Hydroxyethyl starch 130 / 0.4 patent expire?
No public expiry year is available for Hydroxyethyl starch 130 / 0.4 yet; this page updates once verified.
How do I get a quote for Hydroxyethyl starch 130 / 0.4 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24